Temocillin is a recently developed penicillin with a methoxy group in the 6-alpha position. We studied the in-vitro antimicrobial activity against Haemophilus injluenzae and Enterobacteriaceae and the extent of stability to hydrolysis by /Mactamases produced by Gram-negative bacteria. MICs for 76 strains of H. injluenzae were compared with MICs of ampicillin. MICs for 130 strains of Enterobacteriaceae (including 65 carbenicillin-resistant strains) and for 27 other Gram-negative rods were compared with carbenicillin, mezlocillin and piperacillin. Thirty-five out of 38 /Mactamase-producing H. injluenzae were inhibited by 2 mg/1 of temocillin and 90% of carbenicillin-resistant Enterobacteriaceae were inhibited by 8 mg/1 of temocillin. Only one strain each of Serratia marcescens and Proteus mirabilis was found to be resistant. No significant enhancement by clavulanic acid on temocillin could be observed in 20 strains of Gram-negative rods producing /Mactamases. Using bioassay methods temocillin was shown to be highly resistant to all /Mactamase extracts tested with the exception of those from Flavobacterium sp.
Introduction
Temocillin (BRL 17421) ( Figure 1 ) is a recently developed /Mactam antibiotic which has a methoxy group in the 6-alpha position which should confer greater stability to /Mactamases produced by Gram-negative organisms (Slocombe et ai, 1981) . One of the major deficiencies of penicillins has been the instability to Gram-negative /Mactamases. On the other hand, several cephalosporins are now available that are able to withstand most /Mactamases. This investigation therefore examined the activity of this compound against organisms which commonly produce /Mactamases. We have tested the activity against /Mactamase-producing and non-/Mactamaseproducing strains of Haemophilus injluenzae and against Enterobacteriaceae and Pseudomonas in some instances highly resistant to carbenicillin. Temocillin was compared with ampicillin against H. injluenzae and against other Gram-negative strains with carbenicillin, mezlocillin and piperacillin. A bioassay method was used to observe the stability of temocillin to hydrolysis by /Mactamase extracts in comparison to hydrolysis of carbenicillin, mezlocillin and piperacillin. 
Materials and Methods

Antibiotics
Temocillin, ampicillin sodium, carbenicillin sodium, and clavulanic acid were provided by Beecham Research Laboratories. Mezlocillin was obtained from Bayer Pharmaceuticals and piperacillin sodium from Cyanamid UK.
Serial two-fold concentrations of antibiotics were made in appropriate solid media for the determination of minimum inhibitory concentrations (MICs) and in 005 M pH 70 phosphate buffer for the preparation of bioassays.
Culture media
Isosensitest agar supplemented with 0-25% lysed horse blood and 01% NAD was used for determination of MICs against H. injluenzae. DST agar (Oxoid) was used for rapidly growing aerobes. The agar used for bioassay was DST supplemented with 3 ml 1 M potassium acid phosphate per 100 ml.
Bacteria Seventy-six strains of H. injluenzae were selected from a collection of strains derived from The London Hospital and other hospital laboratories in Britain (PhilpottHoward & Williams, 1982) . Other Gram-negative organisms were isolated from clinical specimens in The London Hospital and comprised Eschericia coli (31), Klebsiellae (22) , Enterobacter (12), Citrobacter (14), Proteus (28), Providencia (14) and Serratia (9). These were selected to include 65 strains of Enterobacteria sensitive to carbenicillin (MICs < 16 mg/1) and 65 strains of Enterobacteria resistant to carbenicillin (MICs 32-> 2048 mg/1). Nineteen strains of Pseudomonas and eight strains of related multi-resistant bacteria were included in a further category for examination. Ps. aeruginosa NCTC 10701 was used as the test organism for the bioassay of antibiotics after exposure to /J-lactamases.
Determination of MICs
After incorporation of antibiotic dilutions into appropriate agar a multipoint inoculator was used to place on the plates an inoculum of approximately 10 3 -10 4 cfu. Incubation was in air at 37°C overnight except for H. injluenzae which was incubated in an atmosphere containing 5% CO 2 at 35°C overnight. The MIC was taken as the lowest concentration at which no visible growth of the organisms was seen.
The antibiotic activity of the four antibiotics was also tested with 5 mg/1 clavulanic acid incorporated into agar against 20 strains selected for high resistance to temocillin (MIC> 16 mg/1). 
Preparation of$-lactamase extracts
Thirteen organisms (Table III) were grown at 37 C C in nutrient broth overnight, harvested, washed, re-suspended in 005 M pH 70 phosphate buffer concentrated 20-fold and broken by sonication to release /Mactamases. The supernatant after ultracentrifugation was stored at -20°C in aliquots. Isoelectric focusing of /?-lactamases was carried out on crude enzyme extracts according to the method described by Matthew et al. (1975) .
The /Mactamase extracts comprised ten plasmid-mediated enzymes and three chromosomal enzymes. Tubes containing 1 ml of antibiotics at a concentration of 10 mg/1 were incubated with ten-fold dilutions of enzymes at room temperature for 1 h. The residual antibiotic concentration in the reactive mixture was measured by bioassay, with a range of the antibiotic standards from 0-625 to 10 mg/1. The hydrolysis of the four antibiotics by the enzyme extract was calculated from the residual antibacterial activity in the mixtures. A second series of enzyme extracts from Pseudomonas spp. (6), E. coli (1), Klebsiella (2), Acinetobacter (4), Proteus sp. (1), Enterobacter (1), Flavobacterium (2) were tested at 1 : 10 dilution for ability to hydrolyse temocillin only.
Results
Haemophilus influenzae
MICs 50 and 90 of temocillin and of ampicillin for /Mactamase-producing and non-/Mactamase-producing strains of H. influenzae are shown in Figure 2 . The organisms were divided into three groups: I: ampicillin-sensitive (25 strains), II: ampicillinresistant /Mactamase-negative (13 strains), and III: ampicillin-resistant/Mactamasepositive (38 strains). The MICs of ampicillin and temocillin varied with these different groups of H. influenzae. For the group of /f-lactamase-producing strains temocillin was much more active than ampicillin. Concentrations of 2 and 16 mg/1 respectively inhibited 90% of strains tested. On the other hand, ampicillin was more active than temocillin against ampicillin-sensitive and non-/?-lactamase-producing ampicillin-resistant strains.
Enterobacteriaceae and Pseudomonas
The aerobic Gram-negative rods were divided into three groups for analysis-65 strains of enterobacteria sensitive to carbenicillin, 65 strains resistant to carbenicillin and 27 strains of Pseudomonas and related organisms (Table I) .
Temocillin showed high antimicrobial activity against 130 strains of enterobacteria. MICs of temocillin against 65 strains of carbenicillin-resistant and moderately resistant Enterobacteriaceae were much lower than MICs of carbenicillin. Table I shows that 8 mg/1 of temocillin inhibited 90% of strains of Enterobacteriaceae tested. The only exceptions were two strains, one Pr. mirabilis (MIC 64 mg/1) and the other Ser. marcescens (MIC 512 mg/1). MICs of mezlocillin and piperacillin against these carbenicillin resistant strains were somewhat lower than those of carbenicillin and varied with individual strains. No significant difference could be seen with MICs of the four antibiotics when tested against 65 carbenicillin-sensitive strains (Table I) . Figure 3 shows the cumulative MICs of the four antibiotics against the two categories of enterobacteria carbenicillin-sensitive and carbenicillin-resistant. Nineteen strains of Pseudomonas spp. and eight other related Gram-negative organisms including four Acinetobacter were examined and the MIC 50 and MIC 90 shown in Table I . In 14 out of 19 strains of Pseudomonas spp. MICs of temocillin were four-fold or more greater than those of carbenicillin, while MICs of mezlocillin and piperacillin against these organisms were four-fold or more lower than those of carbenicillin. Piperacillin was the most effective compound, with the MIC against 90% of strains being 128 mg/1. Cumulative MICs for all 27 strains of this category are shown in Figure 4 .
The effect of clavulanic acid on MICs of the four antibiotics against 20 Gramnegative strains was studied. Synergy was not seen for temocillin except possibly in one strain whereas potentiation giving a marked reduction in MIC of four-fold or more was found in six of 20 strains when tested with the other three compounds. Synergy between carbenicillin and clavulanic acid was always accompanied by synergy of clavulanic acid with the other two penicillins. Ten of the more interesting results are tabulated in Table II. There were differences between the four antibiotics in resistance to hydrolysis by /Mactamase extracts and these are shown in Table III . At 1 in 10 dilution of the enzyme extracts listed, hydrolysis of the new compound could not be detected, whilst the other three agents were hydrolysed by higher dilutions of ^-lactamase extracts. Of the second series of enzyme extracts only one, from Flavobacterium, could hydrolyse temocillin. A 1 in 100 dilution after incubation for 1 h produced a 37% loss in activity. This organism (no. 80 in Table II ) needed 512 mg/1 of temocillin for inhibition but the MIC did not change significantly when combined with clavulanic acid.
Discussion
The prevalence of resistance occurring in the Enterobacteriaceae and outside the Enterobacteriaceae often causes difficult problems in chemotherapy. The mechanisms by which bacteria express resistance are manyfold (Davies, 1979) . The production of /Mactamases by these bacteria is the main mechanism of resistance to many /Mactam antibiotics currently available. None of the penicillins which have been described prior to temocillin have been able to withstand hydrolysis by most Gram-negative /Mactamases. The therapy of antibiotic-resistant Gram-negative rods has come to depend upon aminoglycoside or cephalosporin action. Temocillin is the first penicillin which is highly resistant to the /Mactamases. Our study has demonstrated a high in-vitro antibiotic activity against ampicillin-resistant H. influenzae and carbenicillin-resistant enterobacteria. All the /Mactamase-producing H. influenzae were sensitive to temocillin. Thirty-five of 38 strains (90%) were inhibited by 2 mg/1 of temocillin, MICs ranging from 012 to 4 mg/1. Strains of Enterobacteriaceae highly resistant to carbenicillin and ureido penicillins were susceptible to temocillin. The MIC 90 for these strains is less than 8 mg/1 of temocillin, a level readily achievable after parenteral administration. The serum level of temocillin has been reported to be above 20 mg/1 for 8 h after a single intramuscular dose of 500 mg temocillin and 12 mg/1 for 12 h after a single intravenous bolus injection of 1000 mg of temocillin (Slocombe et al., 1981) . The resistant organisms were found mainly amongst the Pseudomonas and Acinetobacter species.
Assessment of /Mactamase stability was based on bioassay of the residual antibiotic after incubation with the enzymes. Studies had been carried out previously to improve the bioassay by the addition of CaCl 2 supplements to the media (Beecham Research Laboratories, pers. comm.). We had found that KH 2 PO 4 produced larger and clearer inhibition zones, probably as an effect of pH stabilisation.
Temocillin proved to be very resistant to all plasmid-mediated and most chromosomal /Mactamase extracts tested. The only enzyme which could hydrolyse temocillin was found in a resistant Flavobacterium; the MIC was not affected by clavulanic acid. The enzyme was therefore either not relevant in the resistance of this organism or not inhibited by clavulanic acid. The lack of significant enhancement by clavulanic acid of the activity of temocillin in other strains confirms the view that temocillin is substantially resistant to /Mactamases which effect the other three penicillins tested.
In our study, temocillin was found less effective than carbenicillin against 14 out of the 19 Pseudomonas spp. by four-fold or more. This may result from a lower permeability of temocillin into Pseudomonas or low affinity to the target enzymes.
Temocillin shows useful activity against many organisms not normally amenable to penicillin therapy. Its role in therapy needs to be assessed in comparison with /Mactamase stable cephalosporins and with penicillin//?-lactamase inhibitor combinations. Penicillins enjoy a much broader usage than cephalosporins in the U.K. The appearance of a /Mactamase stable penicillin presents the possibility of single agent therapy rather than combination therapy.
